GLP-2(T) is a synthetic 39-amino acid dual incretin receptor agonist, classified as a GIP and GLP-1 receptor co-agonist. It is one of the most clinically validated peptides available for metabolic research, with extensive Phase 3 trial data behind it.
How It Works
Co-activation of GLP-1 and GIP receptors produces a synergistic effect resulting in significantly increased insulin response compared to separate administration of each hormone. GLP-2(T) binds the GIP receptor with affinity comparable to native GIP, while engaging the GLP-1 receptor at a lower affinity by design. This intentional balance allows fuller GIP pathway engagement while limiting tolerability issues at higher doses. A fatty diacid moiety attached to the peptide binds to albumin, prolonging its half-life to approximately 5 days.
Where the Research Stands
GLP-2(T) has one of the most extensive clinical research datasets of any peptide in this category. Phase 3 trial data showed mean weight reductions of 15% at lower doses and over 20% at higher doses at week 72. Ongoing research is examining its role in hepatic fat metabolism, cardiovascular outcomes, and metabolic syndrome.
Product Details
- Form: Lyophilized powder
- Size: 10mg per vial
- Purity: ≥99% | COA available on request
- Storage: Keep dry and away from light before reconstitution. Refrigerate after reconstitution.
Research Use Only
GLP-2(T) is intended strictly for laboratory research by qualified professionals. It is not FDA approved and is not for human or animal use. By purchasing, the buyer confirms the product will be used solely for in vitro research in compliance with all applicable laws and regulations.
Reviews
There are no reviews yet.